simendan has been researched along with 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okada, M; Yamawaki, H | 1 |
1 other study(ies) available for simendan and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
| Article | Year |
|---|---|
Levosimendan inhibits interleukin-1β-induced apoptosis through activation of Akt and inhibition of inducible nitric oxide synthase in rat cardiac fibroblasts.
Topics: Amidines; Animals; Apoptosis; Benzylamines; Chromones; Cytochromes c; Cytoprotection; Cytosol; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Gene Expression Regulation, Enzymologic; Hydrazones; Interleukin-1beta; Male; Morpholines; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Pyridazines; Rats; Rats, Wistar; Signal Transduction; Simendan | 2015 |